Filing Details

Accession Number:
0000950170-24-119800
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-01 07:04:51
Reporting Period:
2024-10-31
Accepted Time:
2024-11-01 07:04:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1971543 Mural Oncology Plc MURA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1722673 D. Adam Cutler C/O Mural Oncology Plc
10 Earlsfort Terrace
Dublin 2 L2 D02 T380
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2024-10-31 7,421 $3.41 71,438 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares automatically sold by the Reporting Person to satisfy withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on January 12, 2024, and the sale does not represent a discretionary trade by the Reporting Person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.49. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes 59,144 unvested restricted stock units.